Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infectious Diseases rare diseases Neuropilin-1 drives SARS-CoV-2 infectivity, finds breakthrough study By Staff Reports 5 days ago In a major breakthrough an international team of scientists, led by the University of Bristol,
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 NIH begins large clinical trial to test immune modulators for treatment of COVID-19 By Staff Reports 7 days ago The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 rare diseases Dried blood spot sampling offers an inexpensive way to widen access to antibody testing for COVID-19 By Staff Reports 2 weeks ago Using dried blood spot samples (DBS) is an accurate alternative to venous blood in detecting
Biotechnology Clinical Trials Coronavirus rare diseases Vaccines Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults By Staff Reports 4 weeks ago A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown
Antibiotics Biotechnology Coronavirus Coronavirus COVID-19 Immunotherapies Infection Control Infectious Diseases Some Severe COVID-19 Cases Linked to Genetic Mutations or Antibodies that Attack the Body By Staff Reports 1 month ago People infected by the novel coronavirus can have symptoms that range from mild to deadly.
Biotechnology Cardiology Clinical Trials Coronavirus Coronavirus COVID-19 drug development Infectious Diseases rare diseases Potential new drug to mitigate SARS-CoV-2 infection consequences By Staff Reports 1 month ago Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infectious Diseases rare diseases Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting By Staff Reports 1 month ago Eli Lilly and Company said proof of concept data from an interim analysis of the
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 rare diseases Vaccines Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses By Staff Reports 2 months ago Preclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show
Biotechnology Coronavirus Coronavirus COVID-19 drug development UCI scientists get ‘initial hit’ in developing drug to treat COVID-19 By Staff Reports 3 months ago When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and
Biotechnology Coronavirus Coronavirus COVID-19 COVID-19: Patients Improve After Immune-Suppressant Treatment By Staff Reports 3 months ago Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving a Food and Drug
Coronavirus COVID-19 Moderna’s Coronavirus Vaccine shows ‘Promising’ Safety and Immune response results in Published Phase 1 Study By Staff Reports 3 months ago A Covid-19 vaccine developed by the biotechnology company Moderna in partnership with the National Institutes of Health
Coronavirus Coronavirus COVID-19 rare diseases COVID-19 Fatality Risk Is Double Earlier Estimates By Staff Reports 4 months ago In one of the most robust studies of COVID-19 mortality risk in the United States,
Coronavirus COVID-19 How COVID-19 affects Pediatric Patients By Staff Reports 4 months ago New insights into the clinical and epidemiological characteristics of pediatric patients with coronavirus disease 2019
Biomarkers Coronavirus Immunotherapies Cancer Researchers Have a Head Start in Fight Against COVID-19 By Staff Reports 5 months ago Researchers at Roswell Park Comprehensive Cancer Center have been actively engaged in the effort to develop treatments or
Coronavirus Coronavirus COVID-19 How Communities Can Fight The Coronavirus Pandemic And PPE Shortage By Staff Reports 5 months ago As devastating as Coronavirus (COVID-19) is, there are some bright spots. Consider this: With healthcare
Coronavirus Coronavirus COVID-19 Positive Interim Phase 1 Data for Moderna’s mRNA Vaccine (mRNA-1273) Against Novel Coronavirus Announced By Staff Reports 5 months ago Moderna, Inc., unveiled news on their positive interim clinical data of mRNA-1273, the company’s vaccine
Coronavirus Coronavirus COVID-19 UC San Diego: Marrying molecular farming and advanced manufacturing to develop a COVID-19 vaccine By Staff Reports 6 months ago Nanoengineers at the University of California San Diego are working on a COVID-19 vaccine using
Biotechnology BGI Group helping over 80 countries for timely COVID-19 detection and intervention By Staff Reports 6 months ago Global genomics developer, BGI Group has produced more than 10 million of its Real-Time SARS-CoV-2 tests,
Coronavirus COVID-19 New Coronavirus Test by Abbott Provides Results in as Few as Five Minutes By Staff Reports 7 months ago Abbott has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA)
Biotechnology Coronavirus Pharmaceuticals Prodrug rare diseases FDA clears emergency use of malaria drug, Chloroquine to treat COVID-19 By Staff Reports 7 months ago The Food and Drug Administration has authorized the emergency use of two malaria drugs seen